当前位置:首页 - 行情中心 - 罗欣药业(002793) - 财务分析 - 现金流量表

罗欣药业

(002793)

  

流通市值:44.20亿  总市值:44.26亿
流通股本:10.86亿   总股本:10.88亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,980,500,151.831,386,004,800.46697,946,433.632,344,354,122.44
  收到的税费返还351,543.38303,555.85303,555.853,468,303.6
  收到其他与经营活动有关的现金141,751,275.68133,770,474.7729,303,548.9233,556,341.24
  经营活动现金流入小计2,122,602,970.891,520,078,831.08727,553,538.42,381,378,767.28
  购买商品、接受劳务支付的现金399,426,919.43288,469,796.18126,321,656.94352,584,603.59
  支付给职工以及为职工支付的现金411,319,086.36283,070,610.27145,481,515.27577,898,716.49
  支付的各项税费147,422,745.9398,537,634.4960,274,078.74189,702,765.4
  支付其他与经营活动有关的现金787,365,700.93539,793,239.13253,768,308.321,008,127,003.53
  经营活动现金流出小计1,745,534,452.651,209,871,280.07585,845,559.272,128,313,089.01
  经营活动产生的现金流量净额377,068,518.24310,207,551.01141,707,979.13253,065,678.27
二、投资活动产生的现金流量:
  收回投资收到的现金144,000,0002,000,000-13,504,732.97
  取得投资收益收到的现金102,263.2213,015.94-54,665.24
  处置固定资产、无形资产和其他长期资产收回的现金净额56,00051,00051,0003,801,649.09
  处置子公司及其他营业单位收到的现金净额43,582,254.6341,456,254.6335,884,737.5104,174,083.34
  收到的其他与投资活动有关的现金4,350,0002,900,0002,450,00054,270,100.26
  投资活动现金流入小计192,090,517.8546,420,270.5738,385,737.5175,805,230.9
  购建固定资产、无形资产和其他长期资产支付的现金21,912,997.1114,112,447.844,626,370.3432,183,595.12
  投资支付的现金478,000,0004,000,0004,000,00012,000,000
  支付其他与投资活动有关的现金---7,562,921.43
  投资活动现金流出小计499,912,997.1118,112,447.848,626,370.3451,746,516.55
  投资活动产生的现金流量净额-307,822,479.2628,307,822.7329,759,367.16124,058,714.35
三、筹资活动产生的现金流量:
  吸收投资收到的现金15,170,62015,170,62015,170,6203,637,350
  其中:子公司吸收少数股东投资收到的现金15,170,62015,170,62015,170,6203,637,350
  取得借款收到的现金692,556,100338,656,100189,000,000948,490,000
  收到其他与筹资活动有关的现金381,350,000232,000,000120,000,000354,165,719.3
  筹资活动现金流入小计1,089,076,720585,826,720324,170,6201,306,293,069.3
  偿还债务支付的现金653,056,100280,000,000135,000,0001,209,136,484.99
  分配股利、利润或偿付利息支付的现金31,269,283.8521,882,183.1912,974,871.0848,984,069.43
  支付其他与筹资活动有关的现金466,373,176.42295,228,832.81146,413,085.26383,191,921.33
  筹资活动现金流出小计1,150,698,560.27597,111,016294,387,956.341,641,312,475.75
  筹资活动产生的现金流量净额-61,621,840.27-11,284,29629,782,663.66-335,019,406.45
四、汇率变动对现金及现金等价物的影响-1,313,099.99-5,024,304.35-1,523,243.08-1,229,131.41
五、现金及现金等价物净增加额6,311,098.72322,206,773.39199,726,766.8740,875,854.76
  加:期初现金及现金等价物余额330,265,270.18330,265,270.18329,247,870.08289,389,415.42
  期末现金及现金等价物余额336,576,368.9652,472,043.57528,974,636.95330,265,270.18
补充资料:
  净利润-53,233,137.12--284,526,170.23
  资产减值准备-18,867,184.2-55,335,018.07
  固定资产和投资性房地产折旧-64,597,578.25-149,555,483.91
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-64,597,578.25-149,555,483.91
  无形资产摊销-22,236,146.85-48,030,377.32
  长期待摊费用摊销-1,446,777.76-10,220,205.53
  处置固定资产、无形资产和其他长期资产的损失--330,975.26--3,084,463.82
  固定资产报废损失-7,028.29-1,817,807.96
  公允价值变动损失---35,351,860.47
  财务费用-24,984,102.56-56,080,162.34
  投资损失--13,448,385.21-13,320,728.13
  递延所得税-14,624,620.64--6,192,158.24
  其中:递延所得税资产减少-14,624,620.64-1,165,372.98
    递延所得税负债增加----7,357,531.22
  存货的减少--52,801,998.77-81,290,606.94
  经营性应收项目的减少-205,394,948.57-33,475,639.84
  经营性应付项目的增加--44,131,061.41-27,559,615.38
  其他-12,263,146.62-26,307,819.19
  现金的期末余额-652,472,043.57-330,265,270.18
  减:现金的期初余额-330,265,270.18-289,389,415.42
  现金及现金等价物的净增加额-322,206,773.39-40,875,854.76
公告日期2026-10-272026-08-212026-04-232026-04-23
审计意见(境内)标准无保留意见
TOP↑